Ascorbic acid reduces gentamicin-induced nephrotoxicity in rats through the control of reactive oxygen species

Clinical Nutrition

Volumn 33, Issue 2, 2014, Pages 296-301

  Moreira, Miriam A ^a   Nascimento, Marcos A ^b   Bozzo, Tatiana A ^a   Cintra, Alvaro ^c   Da Silva, Sônia M ^c   Dalboni, Maria A ^a   Mouro, Margaret G ^a,b   Higa, Elisa M S ^a,b,c  

^a Nephrology ^*  (Brazil)

^b Translational Medicine   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute renal failure; Gentamicin; Nitric oxide; Oxidative stress; Vitamin C

Indexed keywords

ASCORBIC ACID; CREATININE; GENTAMICIN; HYDROGEN PEROXIDE; MALONALDEHYDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DISEASE SEVERITY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DAMAGE; KIDNEY TUBULE NECROSIS; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; UREA BLOOD LEVEL;

ACUTE RENAL FAILURE; GENTAMICIN; NITRIC OXIDE; OXIDATIVE STRESS; VITAMIN C;

ACUTE KIDNEY INJURY; ANIMALS; ASCORBIC ACID; CREATININE; GENTAMICINS; HYDROGEN PEROXIDE; KIDNEY; MALE; MALONDIALDEHYDE; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84895506349     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.05.005     Document Type: Article

References (35)

1. Wilson J.X. The physiological role of dehydroascorbic acid. FEBS Lett 2002, 527:5-9.
2. Sureda A., Batle J.M., Tauler P., Aquiló A., Cases N., Tur J.A., et al. Hypoxia/reoxygenation and vitamin C intake influence NO synthesis and antioxidant defenses of neutrophils. Free Radic Biol Med 2004, 37:1744-1755.
3. Hamilton C.A., Brosnan M.J., McIntyre M., Graham D., Dominiczak A.F. Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension 2001, 37:529-534.
4. Vasdev S., Ford C.A., Parai S., Longerich L., Gadag V. Dietary vitamin C supplementation lowers blood pressure in spontaneously hypertensive rats. Mol Cell Biochem 2001, 218:97-103.
5. Vasdev S., Gill V., Parai S., Longerich L., Gadag V. Dietary vitamin E supplementation lowers blood pressure in spontaneously hypertensive rats. Mol Cell Biochem 2002, 238:111-117.
6. Heller R., Munscher-Paulig F., Grabner R., Till U. L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J Biol Chem 1999, 274:8254-8260.
7. Rivas-Cabanero L., Montero A., Lopez-Novoa J.M. Increased glomerular nitric oxide synthesis in gentamicin-induced renal failure. Eur J Pharmacol 1994, 270:119-121.
8. Ali B.H. Gentamicin nephrotoxicity in humans and animals: some recent research. Gen Pharmacol 1995, 26:1477-1487.
9. Rodriguez-Barbero A., Bosque E., Rivas-Cabaero L., Arevalo M., Lopez-Novoa J.M. Effect of platelet activating factor antagonist treatment on gentamicin nephrotoxicity. Mediators Inflamm 1992, 1:23-26.
10. Stojiljkovic N., Stoiljkovic M., Randjelovic P., Veljkovic S., Mihailovic D. Cytoprotective effect of vitamin C against gentamicin-induced acute kidney injury in rats. Exp Toxicol Pathol 2012, 64:69-74.
11. Christo J.S., Rodrigues A.M., Mouro M.G., Cenedeze M.A., de J.Simões M., Schor N., et al. Nitric oxide (NO) is associated with gentamicin (GENTA) nephrotoxicity and the renal function recovery after suspension of GENTA treatment in rats. Nitric Oxide 2011, 24:77-83.
12. Kandeel M., Abdelaziz I., Elhabashy N., Hegazy H., Tolba Y. Nephrotoxicity and oxidative stress of single large dose or two divided doses of gentamicin in rats. Pakistan J Biol Sci PJBS 2011, 14:627-633.
13. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
14. Sardenberg C., Suassuna P., Watanabe R., Cruz Andreoli M.C., Dalboni M.A., Seabra V.F., et al. Balance between cytokine production by peripheral blood mononuclear cells and reactive oxygen species production by monocytes in patients with chronic kidney disease. Ren Fail 2004, 26:673-681.
15. Hampl V., Walters C.L., Archer S.L. Determination of nitric oxide by the chemiluminescence reaction with ozone. Methods in nitric oxide research 1996, Wiley, JWSL. p. 309-318. M. Feelisch, J.S. Stamler (Eds.).
16. Schor N., Ichikawa I., Rennke H.G., Troy J.L., Brenner B.M. Pathophysiology of altered glomerular function in aminoglycoside-treated rats. Kidney Int 1981, 19:288-296.
17. Higa E.M., Schor N., Boim M.A., Ajzen H., Ramos O.L. Role of the prostaglandin and kallikrein-kinin systems in aminoglycoside-induced acute renal failure. Braz J Med Biol Res 1985, 18:355-365.
18. Polat A., Parlakpinar H., Tasdemir S., Colak C., Vardi N., Uscar M., et al. Protective role of aminoguanidine on gentamicin-induced acute renal failure in rats. Acta Histochem 2006, 108:365-371.
19. Slater T.F. Overview of methods used for detecting lipid peroxidation. Methods Enzymol 1984, 105:283-293.
20. Maldonado P.D., Barrera D., Rivero I., Mata R., Medina-Campos O.N., Hernandez-Pando R., et al. Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage. Free Radic Biol Med 2003, 35:317-324.
21. May J.M. How does ascorbic acid prevent endothelial dysfunction?. Free Radic Biol Med 2000, 28:1421-1429.
22. Solzbach U., Hornig B., Jeserich M., Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 1997, 96:1513-1519.
23. Ting H.H., Timimi F.K., Boles K.S., Creager S.J., Ganz P., Creager M.A. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996, 97:22-28.
24. Levine G.N., Frei B., Koulouris S.N., Gerhard M.D., Keaney J.F., Vita J.A. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996, 93:1107-1113.
25. Ellis G.R., Anderson R.A., Lang D., Blackman D.J., Morris R.H., Morris-Thurgood J., et al. Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy. J Am Coll Cardiol 2000, 36:1474-1482.
26. Cooke J.P., Dzau V.J. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997, 48:489-509.
27. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007, 87:315-424.
28. Parlakpinar H., Tasdemir S., Polat A., Bay-karabulut A., Vardi N., Ucar M., Acet A. Protective role of caffeic acid phenethyl ester (cape) on gentamicin-induced acute renal toxicity in rats. Toxicology 2005, 207:169-177.
29. Eiserich J.P., Butler J., van der Vliet A., Cross C.E., Halliwell B. Nitric oxide rapidly scavenges tyrosine and tryptophan radicals. Biochem J 1995, 310(Pt 3):745-749.
30. Rivas-Cabanero L., Rodriguez-Lopez A.M., Martinez-Salgado C., Saura M., Lamas S., Lopez-Novoa J.M. Gentamicin treatment increases mesangial cell nitric oxide production. Exp Nephrol 1997, 5:23-30.
31. Schwartz D., Brasowski E., Raskin Y., Schwartz I.F., Wolman Y., Blum M., et al. The outcome of non-selective vs selective nitric oxide synthase inhibition in lipopolysaccharide treated rats. J Nephrol 2001, 14:110-114.
32. Singer R.F. Vitamin C supplementation in kidney failure: effect on uraemic symptoms. Nephrol Dial Transplant 2011, 26:614-620.
33. Paterson D.L., Robson J.M., Wagener M.M. Risk factors for toxicity in elderly patients given aminoglycosides once daily. J Gen Intern Med 1998, 13:735-739.
34. Sweileh W.M. A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function. Fundam Clin Pharmacol 2009, 23:515-520.
35. Shifow A.A., Kumar K.V., Naidu M.U., Ratnakar K.S. Melatonin, a pineal hormone with antioxidant property, protects against gentamicin-induced nephrotoxicity in rats. Nephron 2000, 85:167-174.